Vimedimex Medi – Pharma JSC (STC:VMD) Debt-to-Asset : 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Vimedimex Medi – Pharma JSC Debt-to-Asset?

Vimedimex Medi – Pharma JSC STC:VMD Debt-to-Asset is 0.00 as of . 20.

Vimedimex Medi – Pharma JSC's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Vimedimex Medi – Pharma JSC's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Vimedimex Medi – Pharma JSC's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in . 20 was ₫0.00 Mil.

Vimedimex Medi – Pharma JSC  (STC:VMD) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Vimedimex Medi – Pharma JSC Debt-to-Asset Related Terms

Vimedimex Medi – Pharma JSC Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Vimedimex Medi – Pharma JSC's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vimedimex Medi – Pharma JSC Debt-to-Asset Chart

Vimedimex Medi – Pharma JSC Annual Data
Trend
Debt-to-Asset

Vimedimex Medi – Pharma JSC Quarterly Data
Debt-to-Asset

STC:VMD vs GOVX, MBVXQ, HSTC: Debt-to-Asset Comparison

For the Biotechnology subindustry, Vimedimex Medi – Pharma JSC's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vimedimex Medi – Pharma JSC Debt-to-Asset vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vimedimex Medi – Pharma JSC's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Vimedimex Medi – Pharma JSC's Debt-to-Asset falls into.


Vimedimex Medi – Pharma JSC Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Vimedimex Medi – Pharma JSC's Debt-to-Asset for the fiscal year that ended in . 20 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=( + ) /
=N/A

Vimedimex Medi – Pharma JSC's Debt-to-Asset for the quarter that ended in . 20 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=( + ) /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.00 mean?
Vimedimex Medi – Pharma JSC (STC:VMD) has a Debt-to-Asset of 0.00 as of . 20. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Vimedimex Medi – Pharma JSC and its competitors.
Is Vimedimex Medi – Pharma JSC's Debt-to-Asset too high?
Vimedimex Medi – Pharma JSC's current Debt-to-Asset is 0.00.
How does Vimedimex Medi – Pharma JSC's Debt-to-Asset compare to GOVX and MBVXQ?
Vimedimex Medi – Pharma JSC's Debt-to-Asset of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Biotechnology company?
A good Debt-to-Asset depends on the Biotechnology industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Vimedimex Medi – Pharma JSC and its competitors. Vimedimex Medi – Pharma JSC's current Debt-to-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimedimex Medi – Pharma JSC stock overvalued right now?
Vimedimex Medi – Pharma JSC (STC:VMD) has a current Debt-to-Asset of 0.00. The current Debt-to-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Vimedimex Medi – Pharma JSC (STC:VMD), the current Debt-to-Asset is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vimedimex Medi – Pharma JSC Business Description

Address 246 Cong Quynh Street, Pham Ngu Lao Ward, District 1, Ho Chi Minh City, VNM
Vimedimex Medi - Pharma JSC is engaged in the production, trading, import, and export of medicines, raw materials for making medicines, biological products, cosmetics, functional foodstuffs, medical equipment, and testing chemicals. It is also involved in renting office buildings; operates bonded warehouses and pharmacy-GSP.